Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
Medscape23h
Why Topical Retinoids Are a Key Component of Every Acne Regimen
The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.
Endo, Inc.: Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora Cream in Canada
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...